Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery
Launched by MAHIDOL UNIVERSITY · Jun 30, 2015
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
Hypertrophic scars are common conditions that cause persistent symptom and can lead to severe psychosocial impairment. Intralesional corticosteroid have been a mainstay in the treatment of hypertrophic scars. However, there are many disadvantages of corticosteroid injection such as severe pain, skin atrophy, skin thinning, steroid acne, telangiectasia and hypopigmentation.
Recent reports propose new treatment methods for hypertrophic scars with the use of fractional ablative lasers to create zones of ablation of the skin that may assisted the penetration of drugs to the skin.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female subjects with age range 18-60 years;
- • Subject with hypertrophic scar from abdominal surgery for at least 3 months;
- • Discontinued using oral isotretinoin for 6 months, alpha hydroxy acid or topical retinoic acid for 3 months
- Exclusion Criteria:
- • Subject who has skin Infection, photosensitive dermatosis or inflammatory acne on the treated area;
- • Subject who smoke cigarette;
- • Subject who was treated with Intralesional corticosteroid
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials